StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)

Close on Nov 17, 2026Market cap $7.00BP/E –Yield –

CG Oncology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CG Oncology's profit margin for the twelve months ending Sep 30, 2026 was -3851.1%. For fiscal 2025 it was -3985.0%, against -7729.5% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3985.0%+3744.5
FY2024Dec 31, 2024-7729.5%+16097.5
FY2023Dec 31, 2023-23827.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-3546.8%−917.3
Q2 FY2026Jun 30, 2026-6832.8%+59421.0
Q1 FY2026Mar 31, 2026-5558.8%+1414.4
Q4 FY2025Dec 31, 2025-1779.0%+45674.5
Q3 FY2025Sep 30, 2025-2629.5%+14399.3
Q1 FY2025Mar 31, 2025-66253.8%−63052.7
Q4 FY2024Dec 31, 2024-6973.2%+1648526.8
Q3 FY2024Sep 30, 2024-47453.5%+83302.1
Q2 FY2024Jun 30, 2024-17028.8%−12559.2
Q1 FY2024Mar 31, 2024-3201.1%–
Q4 FY2023Dec 31, 2023-1655500.0%–
Q3 FY2023Sep 30, 2023-130755.6%–
Q1 FY2023Mar 31, 2023-4469.6%–

More CG Oncology figures

See a number that looks wrong?